SEI Investments’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.43M | Sell |
138,346
-24,060
| -15% | -$1.16M | 0.01% | 1364 |
|
|
2026
Q1 | $8.39M | Buy |
162,406
+7,795
| +5% | +$397K | 0.01% | 1233 |
|
|
2025
Q4 | $7.68M | Buy |
154,611
+1,155
| +0.8% | +$56.2K | 0.01% | 1179 |
|
|
2025
Q3 | $7.33M | Sell |
153,456
-116,450
| -43% | -$4.69M | 0.01% | 1139 |
|
|
2025
Q2 | $8.51M | Buy |
269,906
+25,807
| +11% | +$827K | 0.01% | 1050 |
|
|
2025
Q1 | $7.99M | Sell |
244,099
-52,816
| -18% | -$1.87M | 0.01% | 1063 |
|
|
2024
Q4 | $10.7M | Sell |
296,915
-16,825
| -5% | -$592K | 0.01% | 956 |
|
|
2024
Q3 | $9.78M | Sell |
313,740
-23,918
| -7% | -$746K | 0.01% | 1005 |
|
|
2024
Q2 | $9.03M | Buy |
337,658
+7,078
| +2% | +$205K | 0.01% | 973 |
|
|
2024
Q1 | $11.3M | Buy |
330,580
+64,752
| +24% | +$1.93M | 0.02% | 861 |
|
|
2023
Q4 | $7.69M | Sell |
265,828
-1,446
| -0.5% | -$38.3K | 0.01% | 999 |
|
|
2023
Q3 | $7.37M | Sell |
267,274
-1,451
| -0.5% | -$44.2K | 0.01% | 990 |
|
|
2023
Q2 | $8.08M | Sell |
268,725
-36,362
| -12% | -$1.27M | 0.01% | 981 |
|
|
2023
Q1 | $11.1M | Buy |
305,087
+37,490
| +14% | +$1.44M | 0.02% | 781 |
|
|
2022
Q4 | $9.55M | Buy |
267,597
+23,076
| +9% | +$802K | 0.02% | 748 |
|
|
2022
Q3 | $8.28M | Buy |
244,521
+18,127
| +8% | +$590K | 0.02% | 852 |
|
|
2022
Q2 | $6.55M | Buy |
226,394
+3,245
| +1% | +$92.9K | 0.01% | 970 |
|
|
2022
Q1 | $7.22M | Buy |
223,149
+5,196
| +2% | +$159K | 0.01% | 928 |
|
|
2021
Q4 | $6.36M | Sell |
217,953
-7,233
| -3% | -$219K | 0.01% | 1009 |
|
|
2021
Q3 | $6.01M | Buy |
225,186
+26,238
| +13% | +$704K | 0.01% | 998 |
|
|
2021
Q2 | $6.13M | Buy |
198,948
+17,645
| +10% | +$541K | 0.01% | 974 |
|
|
2021
Q1 | $4.75M | Sell |
181,303
-40,773
| -18% | -$1.14M | 0.01% | 1046 |
|
|
2020
Q4 | $5.59M | Sell |
222,076
-18,786
| -8% | -$404K | 0.01% | 923 |
|
|
2020
Q3 | $5.02M | Buy |
240,862
+22,831
| +10% | +$518K | 0.01% | 867 |
|
|
2020
Q2 | $5.18M | Buy |
218,031
+59,489
| +38% | +$1.31M | 0.02% | 844 |
|
|
2020
Q1 | $2.85M | Sell |
158,542
-155,435
| -50% | -$3.27M | 0.01% | 1000 |
|
|
2019
Q4 | $7.45M | Sell |
313,977
-5,154
| -2% | -$125K | 0.02% | 711 |
|
|
2019
Q3 | $8.75M | Buy |
319,131
+97,345
| +44% | +$2.88M | 0.02% | 655 |
|
|
2019
Q2 | $7.38M | Buy |
221,786
+15,353
| +7% | +$526K | 0.02% | 731 |
|
|
2019
Q1 | $7.26M | Sell |
206,433
-9,507
| -4% | -$354K | 0.02% | 706 |
|
|
2018
Q4 | $10.3M | Buy |
215,940
+30,577
| +16% | +$1.31M | 0.04% | 534 |
|
|
2018
Q3 | $9.34M | Sell |
185,363
-42,275
| -19% | -$2.09M | 0.03% | 558 |
|
|
2018
Q2 | $13.6M | Sell |
227,638
-4,464
| -2% | -$231K | 0.05% | 434 |
|
|
2018
Q1 | $10.6M | Buy |
232,102
+3,546
| +2% | +$148K | 0.04% | 487 |
|
|
2017
Q4 | $9.11M | Sell |
228,556
-19,637
| -8% | -$776K | 0.03% | 647 |
|
|
2017
Q3 | $9.93M | Sell |
248,193
-11,892
| -5% | -$515K | 0.04% | 604 |
|
|
2017
Q2 | $11.2M | Buy |
260,085
+60,303
| +30% | +$2.15M | 0.04% | 504 |
|
|
2017
Q1 | $6.25M | Sell |
199,782
-7,316
| -4% | -$196K | 0.03% | 698 |
|
|
2016
Q4 | $5.23M | Buy |
207,098
+52,418
| +34% | +$1.17M | 0.03% | 742 |
|
|
2016
Q3 | $3.82M | Buy |
154,680
+6,510
| +4% | +$147K | 0.02% | 816 |
|
|
2016
Q2 | $3.02M | Buy |
148,170
+5,703
| +4% | +$101K | 0.02% | 842 |
|
|
2016
Q1 | $2.17M | Sell |
142,467
-69,926
| -33% | -$912K | 0.01% | 948 |
|
|
2015
Q4 | $2.85M | Buy |
212,393
+75,673
| +55% | +$1.17M | 0.02% | 859 |
|
|
2015
Q3 | $1.92M | Buy |
136,720
+65,320
| +91% | +$1.21M | 0.02% | 820 |
|
|
2015
Q2 | $1.21M | Buy |
+71,400
| New | +$1.02M | 0.01% | 921 |
|
Other funds holding SUPN
AC
NAMI
SIMG
SEI Investments's SUPN Position: Q2 2026 in Review
SEI Investments reduced its Supernus Pharmaceuticals (SUPN) stake by 15% in Q2 2026, selling an estimated $1.16M and leaving 138,346 shares worth $6.43M. The position accounts for 0.01% of the portfolio, ranked #1364.
SEI Investments first reported a position in SUPN in Q2 2015 and has held it in 45 quarters since. The position peaked at $13.6M in Q2 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- SEI Investments held 138,346 shares of Supernus Pharmaceuticals worth $6.43M as of Q2 2026.
- SEI Investments sold 24,060 Supernus Pharmaceuticals shares in Q2 2026, an estimated $1.16M.
- Supernus Pharmaceuticals made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1364 holding.
- SEI Investments first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 45 quarters since.
- SEI Investments's Supernus Pharmaceuticals position peaked at $13.6M in Q2 2018.
- 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.